UNSPSC 51412803: Etafenone hydrochloride

This classification denotes a beta-adrenergic agonist with the molecular formula C21H27NO2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NTS160XKGC, chemically known as l.g.11,457 but more generally known as etafenone hydrochloride, which bears US NIH Compound Identifier 3275. European Medicines Agency schedules Etafenone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01980MIG.

Most nations, for tariff and trade purposes, schedule etafenone hydrochloride under HS 29221980 and SITC 51461. As of Q4 2014, ETAFENONE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Etafenone hydrochloride bears US NLM identifiers UMLS ID C0105278 and NCI Concept Code C95811. SMILES: CCN(CC)CCOC1CCCCC1C(=O)CCC2CCCCC2.CL.

UNSPSC 51412803 Etafenone hydrochloride, a Commodity code, covers pharmaceutical preparations used in emergency medical response — specifically advanced life support medications supplied to municipal fire and rescue services. The recent activity under this code reflects state and local procurement of emergency pharmaceuticals for paramedic protocols and acute-care interventions, including vasopressors, cardiac agents, and other parenteral medications that meet OSHA Hazard Communication Standards and carry expiration-date guarantees. Issuing bodies soliciting under this code include municipal fire departments and rescue services operating within county health and emergency response frameworks. The City of Tampa's Purchasing Department represents the primary recent buyer in the dataset, procuring advanced life support medications for Tampa Fire Rescue in support of emergency medical services delivery across Hillsborough County.

Activity under this code is concentrated in Florida, based on the single recent solicitation posted. The City of Tampa issued IFB 26P00188 on April 24, 2026, with response deadline April 8, 2026 (noted as posted after the deadline, indicating a prior posting cycle), seeking four advanced life support medication line items including Labetalol HCI, Epinephrine, Adenosine, and Diltiazem — a representative mix of parenteral cardiac and hemodynamic agents used in paramedic protocols. The estimated contract value was $40,000.00 with a one-year term and optional two-year renewals. The solicitation carried a Small Local Business Enterprise (SLBE) sheltered-market designation with a 5 percent bid discount not to exceed $10,000, and required delivery within ten calendar days of order receipt with nine-month minimum expiration guarantees and 365-day material warranties. Award was to be made to the lowest responsive, responsible bidder within 120 days of bid opening.